Literature DB >> 19369616

Middle ear adenoma: a challenging diagnosis.

E Zan1, C J Limb, J F Koehler, D M Yousem.   

Abstract

Middle ear adenomas are rare benign tumors, which can easily be mistaken for other conditions radiologically. They derive from the middle ear mucosa. We report the case of a 48-year-old man with a history of decreased left-sided hearing and intermittent pulsatile tinnitus. High-resolution CT of the temporal bones revealed a well-defined left middle ear soft-tissue attenuation abutting the head of the malleus. Surgical excision revealed a middle ear adenoma.

Entities:  

Mesh：

Year:  2009        PMID： 19369616     DOI： 10.3174/ajnr.A1534

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


  5 in total

1.  [Neuroendocrine adenoma of the middle ear].

Authors:  S M Gut; B Wagner; M Kessler; T Linder
Journal:  HNO       Date:  2014-03       Impact factor: 1.284

2.  Clinical and histopathological principles for the diagnosis of a recurrent paraganglioma of the jugular foramen initially diagnosed as a middle ear adenoma: illustrative case.

Authors:  Jeffrey M Breton; Knarik Arkun; Arthur S Tischler; Adnan S Qamar; Jonathan S Sillman; Carl B Heilman
Journal:  J Neurosurg Case Lessons       Date:  2021-08-02

3.  Neuroendocrine Adenoma of Middle Ear Causing Acute Onset Facial Palsy- A Rare Case Report.

Authors:  Shakeel-Uz Zaman; Iqra Zakir; Qazi Faraz; Amal-Asif Ahmed; Praneta Kulloo; Shakil Aqil
Journal:  Iran J Otorhinolaryngol       Date:  2019-09

4.  111In-Octreoscan SPECT/CT hybrid imaging and 68Ga-DOTANOC PET/CT in neuroendocrine adenoma of the middle ear (NAME).

Authors:  Mariano Pontico; Viviana Frantellizzi; Laura Cosma; Giuseppe De Vincentis
Journal:  Indian J Radiol Imaging       Date:  2020-10-15

Review 5.  Middle Ear Neuroendocrine Tumor: A Case Report and Review of the Literature in Pediatric Population.

Authors:  Mariapaola Guidi; Annamaria Buccoliero; Franco Trabalzini
Journal:  J Int Adv Otol       Date:  2021-03       Impact factor: 1.316
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.